Having trouble viewing this email? View in your browser.

ECCMID 2018 Wrap-Up

Dear ECCMID 2018 attendees

This year’s 28th European Congress of Clinical Microbiology and Infectious Diseases ECCMID 2018 has come to a close with record-breaking numbers! As many as 12,949 people from 128 countries attended ECCMID with the top 10 countries of provenance being the United States, Spain, United Kingdom, France, Germany, Italy, Netherlands, Switzerland, Belgium, and for the first time China moved into the top 10. The congress featured more than 150 sessions with invited speakers covering the entire field of infectious diseases and clinical microbiology, including eight keynote lectures, more than 100 symposia and oral sessions, 22 educational workshops and 22 meet-the-expert sessions. ECCMID 2018 featured a successful pipeline corner where smaller companies present their experimental products and open forum discussions on hot topics including antimicrobial resistance and sepsis. The congress also offered attendees 29 industry-organized symposia and an exhibition with 198 exhibitors. Of the 5,500 regular and late-breaking abstracts received from 116 different countries, 3,563 abstracts were presented in oral, eposter and paper poster sessions. As many as 370 speakers and 206 chairs participated in the congress and about 42% of this total of 576 were women. More than 70 journalists were registered for the congress, and ESCMID published 11 press releases.

Congress highlights

The programme offered sessions on crowd-drawing topics including antimicrobial resistance, susceptibility testing, antimicrobial stewardship and infection prevention and control as well as sepsis, novel diagnostic techniques, emerging infections, and the microbiome. The congress also extensively covered the big four in infectious diseases HIV, viral hepatitis, tuberculosis and malaria from different aspects. They were presented in keynote sessions, original research and in workshops. The highlights of this year’s congress included keynote lectures, the late-breaker session on clinical trial results, the award lectures and the popular year-in sessions. Disease evolution specialists Colin A. Russell held a keynote on influenza pandemics on the 100th anniversary of the 1918 “Spanish” flu. Another notable lecture was given by Nobel Prize winner Rolf M. Zinkernagel who discussed virus mechanisms to that affect immunity but also explain the success and failures of vaccines. Otto Cars showed how collective global action is needed to manage the crisis of antimicrobial resistance by balancing innovation access and stewardship. Christian Drosten addressed the emergence of novel coronaviral diseases, and George L. Daikos provided an overview of new agents with potential activity against XDR Gram-negative bacterial infections. In her keynote speech Nathalie Questembert-Balaban addressed how bacteria evolve different strategies to evade antibiotic treatments. On the final day of the congress Christopher Dye elaborated on the challenges we are facing to eliminate tuberculosis, while Colin Hill discussed the real meaning and applications of understanding microbiome data and the impact that it may have on future antimicrobial discoveries.

More information on eccmidlive.org, in eLibrary, press releases

You may read more about the highlights of the congress in the press releases on the conference website, which include basic research discussing new markers and targets as well as clinical study results assessing antibiotic treatment courses, infection control and prevention, emerging infections, and vaccine strategies to contain infections. Video clips featuring interviews with keynote speakers, session chairs and other speakers on the scientific highlights may also be found on the society’s ECCMID 2018 channel with many more summaries being posted over the coming days. Abstracts, presentations and webcasts from this year’s ECCMID will be freely available on ECCMID Live until the end of August. ECCMID material is currently being curated to be included in the ESCMID eLibrary, which also hosts material from other ESCMID events. The next ECCMIDs will take place in Amsterdam from 13 – 16 April 2019.

Safe travels and see you next time!

Best regards, your ESCMID communications editors

ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.